
<!doctype html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <title>Development of enzyme antidotes against organophosphorus compounds poisoning</title>
    <meta name="viewport" content="width=device-width">
   
    <!-- Custom CSS -->
    <link rel="stylesheet" href="/css/screen.css">
</head>
<body class="  ">
	<div id="wrapper" class="sof_page container">
		<div id="sof_page_holder">
			<div id="sof_page_menu" class="menu">
				<ul class="container">
					<li class="sof_menu_logo "><a href=""></a></li>
					<li class="menu_item  menu_selected     menu_border"><a href="/science-of-future">Author</a></li>
					<li class="menu_item  menu_border"><a href="/science-of-future-section">Section</a></li>
					<li class="menu_item    menu_border last_menu_item"><a href="/science-of-future-so">Scientific<br>Organization</a></li>
				</ul>
			</div>
			<div id="sof_page_container" class="container">
				<div id="top_bar">
					<div id="prev_page"><a href="#" onclick="window.history.go(-1); return false;">PREVIOUS PAGE</a></div>
					<div id="search">
						<input type="text">
						<button type="submit"></button>
					</div>
				</div>



<div id="report_holder">
	<div id="report_info">
		<div class="section">SECTION: <span>Life Science</span></div>
		<div>SCIENTIFIC ORGANIZATION:<br><span>Lomonosov Moscow State University, School of Chemistry</span></div>
		<div>REPORT FORM: <br><span>«Poster report»</span></div>
		<div>AUTHOR(S)<br> OF THE REPORT: <br><span> Ilya Lyagin,  Elena Efremenko,  Natalia Klyachko,  Alexander Kabanov</span></div>
	</div>
	<div id="report">
		<div id="report_brief">
			<div>SPEAKER:<br><span>Ilya Lyagin</span></div>
			<div>REPORT TITLE:<br><span>Development of enzyme antidotes against organophosphorus compounds poisoning</span></div>
		</div>
		<div id="talking_points">
			TALKING POINTS:<br>
			<p>Organophosphorus compounds (OPC’s) represents highly dangerous substances causing multiple pathogenesis. Thus development of antidote and protective modalities acting on OPC’s is necessary. To obtain such modality, a genetically modified OPH containing hexahistidine tag on the N-terminus of protein globule (His6-OPH) was used. Complexing the enzyme with different block polyanions led to stable non-immunogenic nano-formulation (nano-OPH) with a median size 50±20 nm. Nano-OPH displays long circulation in blood (at least 17 h) after intravenous, intraperitoneal and intramuscular administrations, and overall has very good bioavailability (up to 30%). Nano-OPH administered in white Sprague Dawley rats 1 h before intoxication provided perfect protection against OPC (Paraoxon). Thus the protection ratio (ratio of LD50 of protected animals to LD50 of non-protected animals) was 5.8±0.2 at nano-formulation dose 2500±190 U/kg 1 h pre exposure. Moreover, nano-OPH acted as an antidote resulting in complete survival of animals upon administering 1 min post exposure 1070±60 U/kg of nano-OPH to rats given 4.9×LD50 (4.4×LD100) of Paraoxon.</p>
		</div>
		<div class="print" onClick="window.print()"></div>
	</div>
</div>



			</div>
		</div>
	</div>
	<script src="js/jquery-1.8.3.min.js"></script>
  	<script src="js/functions."></script>
</body>
</html> 